Literature DB >> 6230910

Percutaneous transluminal coronary angioplasty in acute myocardial infarction.

C J Pepine, X Prida, J A Hill, R L Feldman, C R Conti.   

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has, in general, been restricted to therapy for patients with angina pectoris. Thrombolytic therapy and guide wire recanalization have been used to recanalize coronary arteries in patients with evolving myocardial infarction. Recently we and others have examined the use of PTCA to recanalize the acutely occluded artery associated with the early evolving phase of myocardial infarction. PTCA was performed as definitive therapy in eight patients with acute myocardial infarction. Seven of these had totally occluded arteries to the region of infarct. The infarct-related artery was open within 20 minutes in each of these cases. PTCA recanalization resulted in evidence for reperfusion in each case. Residual stenoses either were not present or were minimal. The procedure was well tolerated. These preliminary results suggest that PTCA may be a reasonable alternative to intracoronary thrombolytic therapy in certain patients with acute evolving myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230910     DOI: 10.1016/0002-8703(84)90352-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Treating myocardial infarction in the post-GUSTO era. A European perspective.

Authors:  M J de Boer; F Zijlstra
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

2.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Angioplasty of an occluded left anterior descending coronary artery: usefulness of retrograde opacification of the distal part of the occluded vessel via the contralateral coronary artery in positioning the balloon catheter.

Authors:  G Grollier; P Commeau; J C Potier
Journal:  Br Heart J       Date:  1986-10

Review 4.  Cardiac ischemia. Part II--Reperfusion and treatment.

Authors:  G A Langer; G D Buckberg; J H Tillisch
Journal:  West J Med       Date:  1987-07

5.  Direct measurement of free radical generation following reperfusion of ischemic myocardium.

Authors:  J L Zweier; J T Flaherty; M L Weisfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  Assessment of area at risk and efficacy of treatment in patients with acute coronary syndrome using 99mTc tetrofosmin imaging in humans.

Authors:  H Matsuo; S Watanabe; Y Nishida; T Matsubara; M Kano; A Sugiyama; Y Matsuno; H Oda; Y Kotoo; H Oohashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 7.  Indications for coronary angioplasty in acute myocardial ischemic syndromes.

Authors:  P J de Feyter; P W Serruys; P G Hugenholtz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

8.  Intracoronary thrombolysis: organizational prerequisites, technique, and results.

Authors:  W Rutsch; H Schmutzler
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.